News In Theranostics
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
Mon Mar 17 2025
Telix Adds Lead-212 Isotope Production Capability
Thu Mar 13 2025
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Tue Mar 11 2025
177-Lutetium-PSMA vs Cabazitaxel: A Real-World mCRPC Study - Mike Wenzel
Mon Mar 03 2025
Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics
Thu Feb 27 2025
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases
Wed Feb 26 2025
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
Wed Feb 26 2025
ASCO GU 2025: Seeing Is Believing: Radiographic Criteria to Assess Response
Thu Feb 13 2025
New PET tracer developed for breast cancer
Fri Feb 14 2025
Radiopharmaceutical Industry Trends Shaping 2025
Thu Feb 20 2025
Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial
Tue Jan 28 2025
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
Thu Jan 16 2025
Clarity to present COBRA and CLARIFY abstracts at two world-leading conferences
Tue Jan 28 2025
